10 August 2018
Visiongain has launched a new pharma report World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs
The future of the anti-cancer drugs market looks promising, as a number of new and innovative therapies are coming on to the market. In recent years there has been a remarkable improvement in the safety of products, with improvements of delivery of chemotherapy, among other techniques, reducing the toxicity of treatments.
The lead analyst of the report commented “’The anti-cancer treatments market will see strong growth driven by the ageing population, increasing demand of biological and targeted drug therapies, continuous patent expiry of major cancer drugs with generic competition eroding their share of the market and the rising uptake of biosimilars.
The anti-cancer drugs pipeline includes monoclonal antibodies, new classes of novel antineoplastics (including PARP inhibitors) and therapeutic vaccines. The launch of emerging classes, including immuno-oncologics, and combination therapies will offer potential breakthrough in cancer treatment. On a global context, the US will remain the largest market while emerging markets will see the highest rate of growth”
Leading companies featured in the report include AstraZeneca, Merck & Co., Inc. (Merck), Novartis, Amgen, Bristol-Myers Squibb (BMS), GlaxoSmithKline (GSK), Johnson & Johnson (J&J), Roche, Eli Lilly and Celgene.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Healthcare has never been more personalized and affordable to anyone. Digital consulting applications use artificial intelligence to provide medical advice based on customized medical history record reviews and general medical information derived from big data inferences.
13 May 2021
The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.
11 May 2021
Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.
11 May 2021
The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.